Robert M. Myers
Founder presso Orbus Therapeutics, Inc.
Profilo
Robert M.
Myers is the founder of Orbus Therapeutics, Inc. Prior to founding Orbus Therapeutics, he worked as a Director at Cogentus Pharmaceuticals, Inc., President & Director at Jazz Pharmaceuticals Plc, Senior Vice President-Commercial Development at ALZA Corp., and Executive Vice President-Pharmaceuticals at Exelixis, Inc. He received his undergraduate, graduate, and MBA degrees from Stanford University.
Posizioni attive di Robert M. Myers
| Società | Posizione | Inizio |
|---|---|---|
Orbus Therapeutics, Inc.
 Orbus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Orbus Therapeutics, Inc. operates as a biopharmaceutical company focused on the development and commercialization of therapies that treat rare diseases. Its product eflornithine is a novel cytostatic agent, which the firm is developing to treat patients with recurrent anaplastic astrocytoma, a rare form of central nervous system cancer. The company was founded by Robert M. Myers and Jason D. Levin in 1998 and is headquartered in Palo Alto, CA. | Founder | - |
Precedenti posizioni note di Robert M. Myers
| Società | Posizione | Fine |
|---|---|---|
Cogentus Pharmaceuticals, Inc.
 Cogentus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cogentus Pharmaceuticals, Inc. develops pharmaceutical products. Its investors include The Keffi Group, Prospect Venture Partners, Ridgeback Capital, Apothecary Capital, and Pinnacle Ventures. The company was founded by Mark A. Goldsmith in 2006 and is headquartered in Menlo Park, CA | Director/Board Member | 18/12/2009 |
| EXELIXIS, INC. | Corporate Officer/Principal | 01/01/2003 |
| ALZA CORPORATION | Corporate Officer/Principal | 01/01/2001 |
| JAZZ PHARMACEUTICALS PLC | President | - |
Formazione di Robert M. Myers
| Stanford University | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| EXELIXIS, INC. | Health Technology |
| JAZZ PHARMACEUTICALS PLC | Health Technology |
| Aziende private | 3 |
|---|---|
ALZA Corp.
 ALZA Corp. Pharmaceuticals: MajorHealth Technology ALZA Corp. provides drug delivery solutions and develops pharmaceutical products. The company applies its delivery technologies to develop pharmaceutical products with enhanced therapeutic value for its own portfolio and for many of the world's leading pharmaceutical companies. The company was founded by Martin Gerstel and Alejandro Zaffaroni in 1968 and is headquartered in Vacaville, CA. | Health Technology |
Cogentus Pharmaceuticals, Inc.
Cogentus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cogentus Pharmaceuticals, Inc. develops pharmaceutical products. Its investors include The Keffi Group, Prospect Venture Partners, Ridgeback Capital, Apothecary Capital, and Pinnacle Ventures. The company was founded by Mark A. Goldsmith in 2006 and is headquartered in Menlo Park, CA | Health Technology |
Orbus Therapeutics, Inc.
Orbus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Orbus Therapeutics, Inc. operates as a biopharmaceutical company focused on the development and commercialization of therapies that treat rare diseases. Its product eflornithine is a novel cytostatic agent, which the firm is developing to treat patients with recurrent anaplastic astrocytoma, a rare form of central nervous system cancer. The company was founded by Robert M. Myers and Jason D. Levin in 1998 and is headquartered in Palo Alto, CA. | Health Technology |
- Borsa valori
- Insiders
- Robert M. Myers
